Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents
- 1 January 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 31 (1) , 133-147
- https://doi.org/10.1016/s0022-3956(96)00047-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Immunological Abnormalities in Patients with Chronic Fatigue SyndromeScandinavian Journal of Immunology, 1994
- A Controlled Clinical Trial with a Specifically Configured RNA Drug, Poly(I). POly(C12U), in Chronic Fatigue SyndromeClinical Infectious Diseases, 1994
- Immunologic Abnormalities Associated with Chronic Fatigue SyndromeClinical Infectious Diseases, 1994
- IntroductionClinical Infectious Diseases, 1994
- Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depressionClinical and Experimental Immunology, 1992
- Psychiatric symptoms, personality and ways of coping in chronic fatigue syndromePsychological Medicine, 1991
- WHAT IS MYALGIC ENCEPHALOMYELITIS?The Lancet, 1988
- PATHOPHYSIOLOGY OF MYALGIC ENCEPHALITISThe Lancet, 1987
- The postviral fatigue syndrome — an analysis of the findings in 50 casesJournal of Infection, 1985
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981